id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-P-0940-0005,FDA,FDA-2021-P-0940,"Response Letter from FDA CDER to Hyman, Phelps & McNamara, P.C.",Other,Approval,2024-11-19T05:00:00Z,2024,11,2024-11-19T05:00:00Z,,2024-11-19T19:55:40Z,,0,0,0900006486828de4
FDA-2021-P-0940-0004,FDA,FDA-2021-P-0940,"Determination That HYDROCORTONE (Hydrocortisone Sodium Phosphate) Injection, Equivalent to 50 Milligrams Base/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2024-11-19T05:00:00Z,2024,11,2024-11-19T05:00:00Z,,2024-11-19T13:25:25Z,2024-26916,0,0,0900006486827d2c